Previous 10 | Next 10 |
2024-04-25 10:30:05 ET Wedbush analyst issues NEUTRAL recommendation for BIIB on April 25, 2024 08:28AM ET. The previous analyst recommendation was Neutral. BIIB was trading at $204.65 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
2024-04-24 18:18:12 ET Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded this performance by trading the stock up by almost 5%. That comp...
2024-04-24 17:04:29 ET Biogen, a global biopharmaceutical company, has seen revenue growth driven by higher returns in the U.S. Operating expenses have evolved, leading to improved net income in Q1 2024. Management focuses on internal initiatives and managing risks like market competition and...
2024-04-24 12:45:15 ET Image source: The Motley Fool. Biogen (NASDAQ: BIIB) Q1 2024 Earnings Call Apr 24, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Biogen (BIIB) Q1 2024 Earnings Call Transcript
2024-04-24 11:25:25 ET Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 05:00 PM ET Company Participants Chuck Triano - Head of Investor Relations Chris Viehbacher - President and Chief Executive Officer Alisha Alaimo - Head and President of Nor...
2024-04-24 08:03:47 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...
2024-04-24 07:45:39 ET Biogen Inc. (NASDAQ: BIIB), a leading biotechnology company, has released its Q1 2024 financial results , showcasing resilience and strategic growth despite facing revenue challenges. In the first quarter of 2024, Biogen reported a revenue of $2.29 billion...
Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...
2024-04-24 06:51:46 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...
2024-04-23 11:01:17 ET More on Biogen Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript) Biogen Inc. (BIIB) TD Cowen 44th Annual Health Care Conference - (Transcript) Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade) Bio...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases ...
TOKYO and CAMBRIDGE, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today tha...
NEW YORK, NY / ACCESSWIRE / June 12, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting ...